[期刊]
  • 《Journal of neuroendocrinology.》 2024年36卷4期

摘要 : Patients with neuroendocrine tumours located in the gastroenteropancreatic tract (GEP-NETs) and treatment with somatostatin analogues (SSA's) are at risk of malnutrition which has been reported previously evaluating weight loss or... 展开

相关作者
相关关键词